Dual HSV/BRAFi therapy had a differential effect on the T cell dynamics of different CD4 +subtypes, such that persistent to arrested transitioning TCR signaling was maintained in a higher percentage of activated Treg than conventional CD4, and these PAt CD4 effectors were the T cell subset which correlated with reduction in tumor growth. Here, CD4 is linked to neoplasm.